Royalty Pharma (RPRX) Shares Repurchased (2019 - 2025)
Historic Shares Repurchased for Royalty Pharma (RPRX) over the last 4 years, with Q4 2025 value amounting to $80.5 million.
- Royalty Pharma's Shares Repurchased rose 5309.18% to $80.5 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.2 billion, marking a year-over-year increase of 43445.58%. This contributed to the annual value of $1.2 billion for FY2025, which is 43445.58% up from last year.
- According to the latest figures from Q4 2025, Royalty Pharma's Shares Repurchased is $80.5 million, which was up 5309.18% from $146.5 million recorded in Q3 2025.
- Over the past 5 years, Royalty Pharma's Shares Repurchased peaked at $708.8 million during Q1 2025, and registered a low of $30.2 million during Q4 2023.
- Its 3-year average for Shares Repurchased is $180.8 million, with a median of $97.0 million in 2024.
- In the last 5 years, Royalty Pharma's Shares Repurchased crashed by 3074.0% in 2024 and then skyrocketed by 26446.96% in 2025.
- Royalty Pharma's Shares Repurchased (Quarter) stood at $30.2 million in 2023, then soared by 74.2% to $52.6 million in 2024, then skyrocketed by 53.09% to $80.5 million in 2025.
- Its Shares Repurchased stands at $80.5 million for Q4 2025, versus $146.5 million for Q3 2025 and $291.6 million for Q2 2025.